Have questions about Spravato for treatment-resistant depression? Our FAQ covers how it works, who qualifies, safety, insurance, and what to expect at Being Health in NYC.

Spravato is FDA-approved and often covered by insurance, while IV/IM ketamine is off-label and typically self-pay. Both can help treatment-resistant depression, but differ in safety oversight, monitoring, and accessibility.

Clinical trials show Spravato can help up to 70% of patients with treatment-resistant depression, with improvements often seen within weeks. Learn what research and real-world outcomes reveal about its effectiveness.

At Being Health, Spravato treatment is more than medication. It’s a supportive, calming experience. Learn what to expect in each session, from private rooms and supervised dosing to safety monitoring and personalized care.

Most major insurers in NYC cover Spravato for treatment-resistant depression. Learn what coverage requires, expected costs, and how Being Health helps patients navigate approvals and minimize out-of-pocket expenses.

Spravato® is an FDA-approved nasal spray for treatment-resistant depression and MDD with suicidal thoughts. See who qualifies, how treatment works, safety protocols, and what to expect at Being Health in NYC.